Cell-density dependent migration in pancreatic ductal adenocarcinoma.

被引:0
|
作者
Karl, M. [1 ]
Jayatilaka, H. [1 ]
Wirtz, D. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA
[2] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA
[3] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA
[4] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA
[5] Johns Hopkins Sch Med, Sydney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
P1283
引用
收藏
页数:2
相关论文
共 50 条
  • [1] T-cell regulation in pancreatic ductal adenocarcinoma.
    Sivakumar, Shivan
    Abu-Shah, Enas
    Ahern, David
    Mangal, Nagina
    Reddy, Srikanth
    Rendek, Aniko
    Soonawalla, Zahir
    Silva, Michael
    Middleton, Mark
    Dustin, Michael L.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 76 - 77
  • [2] Proteogenomic characterizations of pancreatic ductal adenocarcinoma.
    Cao, Liwei
    Huang, Chen
    Zhou, Daniel Cui
    Hu, Yingwei
    Lih, Mamie
    Savage, Sara R.
    Krug, Karsten
    Clark, David J.
    Schnaubelt, Michael
    Chen, Lijun
    Leprevost, Felipe Da Veiga
    Eguez, Rodrigo Vargas
    Nesvizhskii, Alexey I.
    Mani, D. R.
    Omenn, Gilbert S.
    Boja, Emily S.
    Mesri, Mehdi
    Robles, Ana I.
    Rodriguez, Henry
    Bathe, Oliver F.
    Chan, Daniel W.
    Hruban, Ralph H.
    Ding, Li
    Zhang, Bing
    Zhang, Hui
    CANCER RESEARCH, 2021, 81 (22)
  • [3] Proteogenomic characterization of pancreatic ductal adenocarcinoma.
    Cao, Liwei
    Huang, Chen
    Zhou, Daniel Cui
    Bathe, Oliver F.
    Chan, Daniel W.
    Hruban, Ralph H.
    Ding, Li
    Zhang, Bing
    Zhang, Hui
    CANCER RESEARCH, 2021, 81 (13)
  • [4] Auranofin to prevent progression of pancreatic ductal adenocarcinoma.
    Perez, Mayrim V. Rios
    Roife, David
    Dai, Bing Bing
    Kang, Ya'an
    Li, Xinqun
    Pratt, Michael
    Fleming, Jason B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [5] Effect of metformin on survival in pancreatic ductal adenocarcinoma.
    Amin, Sunil
    Mhango, Grace
    Lin, Jenny J.
    Aronson, Anne
    Boffetta, Paolo
    Wisnivesky, Juan P.
    Lucas, Aimee
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [6] Resolving and Targeting the Mechanobiome of Pancreatic Ductal Adenocarcinoma.
    Surcel, A.
    Zhu, Q.
    Schiffhauer, E.
    Anders, R. A.
    Robinson, D. N.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [7] A novel RAS inhibitor for pancreatic ductal adenocarcinoma.
    Arshad, Tariq
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16263 - E16263
  • [8] Impact of site of metastases in pancreatic ductal adenocarcinoma.
    Arshad, Adeel
    Zhao, Songzhu
    Wei, Lai
    Stephens, Julie
    Manne, Ashish
    Noonan, Anne M.
    Rahman, Shafia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 708 - 708
  • [9] Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.
    Ashouri, Karam
    Baca, Yasmine
    Xiu, Joanne
    Soni, Shivani
    Algaze, Sandra
    Jayachandran, Priya
    Wong, Alexandra
    Yang, Yan
    Torres-Gonzalez, Lesly
    Lo, Jae Ho
    Zhang, Wu
    Khushman, Moh'd M.
    Weinberg, Benjamin Adam
    Goel, Sanjay
    Lou, Emil
    Battaglin, Francesca
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 699 - 699
  • [10] Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma.
    Ninomiya, Go
    Fujii, Tsutomu
    Yamada, Suguru
    Asano, Tomonari
    Takano, Nao
    Takami, Hideki
    Iwata, Naoki
    Kanda, Mitsuro
    Niwa, Yukiko
    Hayashi, Masamichi
    Kobayashi, Daisuke
    Tanaka, Chie
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Fujiwara, Michitaka
    Koike, Masahiko
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)